The heart of the Global Health Information Grid is our GEMR (Genotyped Electronic Medical Record ) technology.

"Genotyping without outcome co-relation is mind without body. Outcome analysis without genotyping is body without soul"

Our approach to global health information network ( GHIN ) is GEMR centric and ADR focused. We have introduced the genotype dimension into the EMR to eliminate inconsistency in the therapeutic process. So the output is precise every time. Every time a GEMR will address issues like drug-drug, drug-food and drug-disease interactions besides functioning in lifestyle onto the genotype background of the patient.

Using an innovative 'BioTag' genotyped information can be compressed into handheld / portable devices to enable the use of genotype information at the point of diagnosis / prescription. Unified identity system is yet another spin off of BioTag.

Furthermore, the novel 'Gene-based Therapy' that holds immense potential to cure a host of dreaded diseases, requires customization that can be made possible only by the depth of information our GEMR will provide. Our GEMR will re-engineer the processes in a typical Tele medicine setting. The unified identity systems is yet another spin off of the GEMR technology.

ADVERSE DRUG REACTIONS (ADR)

Our involvement in core research processes led us to confront the problem of Adverse Drug Reactions (ADR), a silent killer. A problem that led to the creation of our current business model. A problem that helped us realize that the cure was bigger than the problem. The only way we could crack the drug reaction issue was by knowing the way genotypes, lifestyle segments, cultural groups and individuals react to drugs. While ADAPT has transformed the drug development and approval process, the loop was incomplete. The ThinkGenŽ GEMR data will solve the hitherto intractable problem of ADRs - with all the implications of enhanced security from litigation, reduced insurance payoffs and shorter drug research cycles. The list of value addition that will emanate from mining such a database is immense.

 

PRESCRIPTION STRATEGY

An explicit advantage emanating from the GEMR-centric, ADR-focused HIN is the automation of and objectivity in prescription strategy. By making available relevant current information at the point of care, and integrating research to application, ThinkGenŽ completes the feedback loop. Real-time information relating to interactions, reactions and then customizing therapy will render the prescription process precise.